Kwality Pharmaceuticals Ltd

Kwality Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kwality Pharmaceuticals Ltd

₹ 260 -3.63%
26 May - close price
kwalitypharma.com BSE: 539997
About

Kwality Pharmaceuticals Limited is an India-based holding company. The Company manufactures and exports pharmaceutical formulations in liquid orals, dry syrups, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations and oral rehydration solution (ORS).

Key Points

Diverse Product Basket
The Co. offers a broad range of finished pharmaceutical formulations in a dosage form viz. Tablets, Capsules, Syrup, Dry Syrup, Injections etc. [1] It has a portfolio of 3000+ formulations in 25+ therapeutic areas. [2] It offers a total of 600 products and a pipeline of 300 products is under registration. [3]

Website BSE
  • Market Cap ₹ 270 Cr.
  • Current Price ₹ 260
  • High / Low ₹ 509 / 248
  • Stock P/E 8.46
  • Book Value ₹ 195
  • Dividend Yield 0.00 %
  • ROCE 18.3 %
  • ROE 16.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 46.9% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 45.3%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 72.2 to 107 days.
  • Working capital days have increased from 113 days to 201 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
120.19 183.71 88.19 64.04 70.22 55.96 56.01 68.80
72.66 100.29 63.65 47.81 52.20 40.39 40.84 57.28
Operating Profit 47.53 83.42 24.54 16.23 18.02 15.57 15.17 11.52
OPM % 39.55% 45.41% 27.83% 25.34% 25.66% 27.82% 27.08% 16.74%
0.96 0.12 0.84 1.60 0.38 0.75 0.35 -15.07
Interest 0.68 0.71 0.50 1.03 1.22 1.18 1.95 1.67
Depreciation 2.06 2.65 3.19 2.75 3.13 3.83 3.54 4.42
Profit before tax 45.75 80.18 21.69 14.05 14.05 11.31 10.03 -9.64
Tax % 24.92% 25.59% 26.74% 25.27% 24.91% 20.07% 27.92% 23.65%
Net Profit 34.35 59.66 15.89 10.51 10.55 9.05 7.23 -7.36
EPS in Rs 33.10 57.50 15.31 10.13 10.17 8.72 6.97 -7.09
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
38 62 60 52 76 95 137 165 138 261 452 251
36 58 56 49 70 86 125 149 124 231 280 191
Operating Profit 2 3 4 4 6 9 12 15 14 29 172 60
OPM % 5% 5% 6% 7% 8% 9% 8% 9% 10% 11% 38% 24%
1 0 0 1 0 2 1 1 4 2 4 -14
Interest 1 1 1 1 1 2 2 2 3 3 3 6
Depreciation 1 1 1 1 2 2 3 3 4 6 11 15
Profit before tax 1 2 2 2 3 6 8 11 11 22 162 26
Tax % 39% 27% 47% 29% 39% 41% 38% 31% 24% 29% 26% 24%
Net Profit 1 1 1 1 2 3 5 8 8 15 120 19
EPS in Rs 0.86 1.66 0.95 1.32 1.89 3.31 4.51 7.28 8.12 14.86 115.70 18.76
Dividend Payout % 0% 0% 0% 0% 0% 9% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 15%
5 Years: 13%
3 Years: 22%
TTM: -45%
Compounded Profit Growth
10 Years: 39%
5 Years: 47%
3 Years: 56%
TTM: -73%
Stock Price CAGR
10 Years: %
5 Years: 41%
3 Years: 95%
1 Year: -38%
Return on Equity
10 Years: 35%
5 Years: 41%
3 Years: 45%
Last Year: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
4 4 4 4 5 5 10 10 10 10 10 10
Reserves 7 8 13 15 18 21 21 28 37 52 172 192
10 6 6 8 13 19 26 28 35 41 54 90
11 11 12 10 17 27 41 40 53 65 106 64
Total Liabilities 32 29 35 38 52 72 98 107 135 169 343 357
9 10 11 11 11 16 19 28 42 56 91 120
CWIP 0 0 0 0 0 0 0 0 0 3 12 14
Investments 1 1 3 4 5 7 9 8 8 9 4 4
22 18 21 23 36 50 70 71 86 102 235 219
Total Assets 32 29 35 38 52 72 98 107 135 169 343 357

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
0 8 -0 1 -3 4 -0 12 6 26 63
-1 -1 -4 -1 -2 -7 -6 -11 -17 -23 -63
1 -5 3 1 5 5 5 -2 12 1 6
Net Cash Flow -0 2 -2 0 0 1 -1 -1 1 4 6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 82 42 41 63 95 87 99 86 80 53 57 107
Inventory Days 114 33 58 61 54 72 54 34 94 38 97 286
Days Payable 93 31 58 40 61 67 79 52 96 58 63 117
Cash Conversion Cycle 104 44 41 85 89 92 74 68 78 33 91 276
Working Capital Days 102 35 60 81 87 79 76 62 99 48 89 201
ROCE % 13% 14% 12% 11% 15% 19% 19% 21% 18% 26% 97% 18%

Shareholding Pattern

Numbers in percentages

Mar 2019 Sep 2019 Mar 2020 Sep 2020 Mar 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
50.14 50.14 51.52 51.52 54.13 54.24 54.24 54.43 54.45 54.44 54.44 54.73
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01
49.86 49.86 48.48 48.48 45.87 45.76 45.76 45.57 45.55 45.56 45.54 45.25

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • May 2022
    Transcript
    Notes
    PPT